Biochemical and Genetic Analysis of Seven Korean Individuals With Suspected Metachromatic Leukodystrophy
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Metachromatic leukodystrophy (MLD) is an autosomal recessive disease caused by a deficiency in arylsulfatase A (ARSA). However, decreased ARSA activity is also observed in pseudodeficiency (PD). To distinguish between MLD and PD, we performed gene mutation and sulfatide analyses by using dried blood spots (DBSs) from seven Korean individuals who underwent an analysis of ARSA activity. DNA was extracted from DBSs, and PCR-direct sequencing of ARSA was performed. The cDNA obtained was analyzed to confirm a novel mutation. Of the seven subjects, three were confirmed as having MLD, one was confirmed as having MLD-PD, one was confirmed as having PD, and the remaining two were obligate heterozygotes. We verified the novel pathogenic variant c.1107+1delG by performing familial and cDNA analyses. Sulfatide concentrations in DBSs were analyzed and were quantified by using ultra-performance liquid chromatography and tandem mass spectrometry, respectively. Total sulfatide concentration was inversely correlated with ARSA activity (Spearman’s coefficient of rank correlation, P=0.929, P=0.0025). The results of this mutational and biochemical study on MLD will increase our understanding of the genetic characteristics of MLD in Koreans.
Abstract
Metachromatic leukodystrophy (MLD) is an autosomal recessive disease caused by a deficiency in arylsulfatase A (ARSA). However, decreased ARSA activity is also observed in pseudodeficiency (PD). To distinguish between MLD and PD, we performed gene mutation and sulfatide analyses by using dried blood spots (DBSs) from seven Korean individuals who underwent an analysis of ARSA activity. DNA was extracted from DBSs, and PCR-direct sequencing of ARSA was performed. The cDNA obtained was analyzed to confirm a novel mutation. Of the seven subjects, three were confirmed as having MLD, one was confirmed as having MLD-PD, one was confirmed as having PD, and the remaining two were obligate heterozygotes. We verified the novel pathogenic variant c.1107+1delG by performing familial and cDNA analyses. Sulfatide concentrations in DBSs were analyzed and were quantified by using ultra-performance liquid chromatography and tandem mass spectrometry, respectively. Total sulfatide concentration was inversely correlated with ARSA activity (Spearman’s coefficient of rank correlation, P=0.929, P=0.0025). The results of this mutational and biochemical study on MLD will increase our understanding of the genetic characteristics of MLD in Koreans.
참고문헌 (17)
- Tan MA, "Biochemical profiling to predict disease severity in metachromatic leukodystrophy", Mol Genet Metab, 99, pp.142~148 (2010)
- Gieselmann V, "Metachromatic leukodystrophy--an update", Neuropediatrics, 41, pp.1~6 (2010)
- Baum H, "The assay of arylsulphatases A and B in human urine", Clin Chim Acta, 4, pp.453~455 (1959)
- "HGMD Mutation Result" (2014)[URL]
- "GeneReviews-Arylsulfatase A Deficiency" (2011)[URL]
- Berger J, "Occurrence, distribution, and phenotype of arylsulfatase A mutations in patients with metachromatic leukodystrophy", Am J Med Genet, 69, pp.335~340 (1997)
- Fluharty AL, "Two new arylsulfatase A (ARSA) mutations in a juvenile metachromatic leukodystrophy (MLD) patient", Am J Hum Genet, 49, pp.1340~1350 (1991)
- Eto Y, "Molecular characteristics in Japanese patients with lipidosis: novel mutations in metachromatic leukodystrophy and Gaucher disease", Mol Cell Biochem, 119, pp.179~184 (1993)
- 강동희, "Identification of a Novel Splicing Mutation in the ARSA Gene in a Patient with Late-infantile Form of Metachromatic Leukodystrophy", Annals of Laboratory Medicine, 30(5), pp.516~520 (2010), 대한진단검사의학회
- 강소연, "백색질장애의 임상적 고찰", 대한소아신경학회지, 19(2), pp.114~122 (2011), 대한소아신경학회
- 이지현, "A Case of Metachromatic Leukodystrophy Confirmed by Molecular Genetic Analysis", 대한소아신경학회지, 19(3), pp.272~276 (2011), 대한소아신경학회
- Han M, "Ultra-performance liquid chromatography", tandem mass spectrometry for determination of sulfatides in dried blood spots from patients with metachromatic leukodystrophy, 2014, pp.28, 587~594
- "Nomenclature for the description of sequence variants"[URL]
- Richards S, "Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med (2015)[DOI]
- Regis S, "Contribution of arylsulfatase A mutations located on the same allele to enzyme activity reduction and metachromatic leukodystrophy severity", Hum Genet, 110, pp.351~355 (2002)
- Gieselmann V, "Arylsulfatase A pseudodeficiency: loss of a polyadenylylation signal and N-glycosylation site", Proc Natl Acad Sci USA, 86, pp.9436~9440 (1989)
- Ricketts MH, "A novel arylsulfatase A protein variant and genotype in two patients with major depression", J Affect Disord, 40, pp.137~147 (1996)